Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Arthritis and Rheumatism|April 11, 2012
Starting dose is a risk factor for allopurinol hypersensitivity syndrome: a proposed safe starting dose of allopurinolLisa K Stamp, William J Taylor, Peter B Jones, et al.
Clinical Pharmacokinetics|March 14, 2013
A population pharmacokinetic model for low-dose methotrexate and its polyglutamated metabolites in red blood cellsJulia Korell, Lisa K Stamp, Murray L Barclay, et al.
Annals of the Rheumatic Diseases|August 24, 2017
Allopurinol dose escalation to achieve serum urate below 6 mg/dL: an open-label extension studyLisa K Stamp, Peter T Chapman, Murray Barclay, et al.
Rheumatology (Oxford, England)|April 28, 2012
Furosemide increases plasma oxypurinol without lowering serum urate--a complex drug interaction: implications for clinical practiceLisa K Stamp, Murray L Barclay, John L O'Donnell, et al.
Clinical Pharmacokinetics|July 28, 2025
The Influence of Patient Factors on the Population Pharmacokinetics of Colchicine: Implications for Safe and Effective DosingDaniel F B Wright, Hailemichael Z Hishe, Nicola Dalbeth, et al.
Rheumatology (Oxford, England)|June 6, 2014
Myeloperoxidase and oxidation of uric acid in gout: implications for the clinical consequences of hyperuricaemiaLisa K Stamp, Rufus Turner, Irada S Khalilova, et al.
British Journal of Clinical Pharmacology|July 13, 2013
Comparison of intracellular methotrexate kinetics in red blood cells with the kinetics in other cell typesJulia Korell, Stephen B Duffull, Judith M Dalrymple, et al.
Pageof 4